Quantum sensors could aid in development of new drugs and nanomedicine

Groundbreaking research has shown a quantum atom has been tracked inside a living human cell and may lead to improvements in the testing and development of new drugs.

Professor Lloyd Hollenberg from the University of Melbourne's School of Physics who led the research said it is the first time a single atom encased in nanodiamond has been used as a sensor to explore the nanoscale environment inside a living human cell.

"It is exciting to see how the atom experiences the biological environment at the nanoscale," he said.

"This research paves the way towards a new class of quantum sensors used for biological research into the development of new drugs and nanomedicine."

The sensor is capable of detecting biological processes at a molecular level, such as the regulation of chemicals in and out of the cell, which is critical in understanding how drugs work.

The paper has been published in the journal Nature Nanotechnology.

Funded by the ARC Centre of Excellence for Quantum Computation and Communication Technology, the research was conducted by a cross-disciplinary team from the University of Melbourne's Physics, Chemistry, and Chemical and Biomolecular Engineering departments.

The researchers developed state of the art technology to control and manipulate the atom in the nanodiamond before inserting it into the human cells in the lab.

Biologist Dr Yan Yan of the University's Department of Chemical and Biomolecular Engineering who works in the field of nanomedicine, said the sensor provides critical information about the movement of the nanodiamonds inside the living cell.

"This is important for the new field of nanomedicine where drug delivery is dependant on the uptake of similar sized nanoparticles into the cell."

Quantum physicist and PhD student Liam McGuinness from the University's School of Physics said that monitoring the atomic sensor in a living cell was a significant achievement.

"Previously, these atomic level quantum measurements could only be achieved under carefully controlled conditions of a physics lab," he said.

It is hoped in the next few years, that following these proof of principle experiments, the researchers will be able to develop the technology and provide a new set of tools for drug discovery and nanomedicine.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
GLP-1 drugs protect brain health by improving neurovascular function and reducing inflammation